首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >Mucinous carcinoma in Crohn’s disease originating in a fistulous tract
【2h】

Mucinous carcinoma in Crohn’s disease originating in a fistulous tract

机译:克罗恩病起源于瘘管的粘液癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Malignant disease, including mucinous carcinomas of the colorectum, may complicate long-standing Crohn’s disease. An 18-year-old male with extensive small and large bowel involvement with Crohn’s disease developed recurrent peri-rectal fistulous disease that persisted for more than a decade despite pharmacological and surgical therapy as well as later therapy with biological agents. Eventually, an extensive and difficult-to-detect mucinous carcinoma developed in the fistulous tract. Although fistula cancer is rarely described in Crohn’s disease, use of immunosuppressant and biological agents may play an initiating or exacerbating role in its development or progression. As potent biological agents are frequently used, often to avoid surgical treatment, clinicians should have an increasingly high index of suspicion for this potential complication, especially if fistulous drainage persists and remains refractory to medical therapy.
机译:恶性疾病(包括结肠直肠粘液癌)可能会使长期存在的克罗恩病复杂化。一名18岁的男性,广泛和大,小肠蠕动都与克罗恩氏病有关,但复发性直肠周围瘘管病仍持续了十多年,尽管进行了药物和外科治疗以及后来的生物制剂治疗。最终,在瘘管中形成了广泛且难以检测的粘液癌。尽管在克罗恩病中很少描述瘘管癌,但是使用免疫抑制剂和生物制剂可能在其发展或进程中起着起始或加剧的作用。由于经常使用有力的生物制剂,通常是为了避免手术治疗,因此临床医生对这种潜在并发症的怀疑程度应该越来越高,尤其是如果瘘管引流持续并且对药物治疗仍然无效的话。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号